J. Goldman & Co LP - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,888,000
-67.5%
177,602
-68.2%
0.14%
-69.0%
Q3 2019$5,813,000
+1793.5%
558,396
+2692.0%
0.44%
+1976.2%
Q2 2019$307,000
-91.4%
20,000
-94.7%
0.02%
-92.4%
Q4 2018$3,563,000
+114.6%
375,000
+275.0%
0.28%
+137.1%
Q3 2018$1,660,000
+3.4%
100,0000.0%0.12%
+39.8%
Q2 2018$1,605,000
+29.2%
100,000
+23.2%
0.08%
+56.6%
Q1 2018$1,242,000
+59.2%
81,200
+62.4%
0.05%
+29.3%
Q4 2017$780,000
-30.7%
50,000
-50.6%
0.04%
-28.1%
Q3 2017$1,125,000
+1.9%
101,316
-15.6%
0.06%
-5.0%
Q2 2017$1,104,000
-7.8%
120,000
-14.3%
0.06%
+1.7%
Q1 2017$1,197,000
-44.0%
140,000
-30.0%
0.06%
-58.5%
Q4 2016$2,139,000199,8860.14%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q2 2017.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders